HomeCompareNINOF vs MRK

NINOF vs MRK: Dividend Comparison 2026

NINOF yields 1.97% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $35.9K in total portfolio value
10 years
NINOF
NINOF
● Live price
1.97%
Share price
$13.68
Annual div
$0.27
5Y div CAGR
-17.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$30.23
Full NINOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NINOF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNINOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NINOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NINOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NINOF
Annual income on $10K today (after 15% tax)
$167.76/yr
After 10yr DRIP, annual income (after tax)
$25.70/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,302.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NINOF + MRK for your $10,000?

NINOF: 50%MRK: 50%
100% MRK50/50100% NINOF
Portfolio after 10yr
$38.8K
Annual income
$4,914.18/yr
Blended yield
12.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NINOF
No analyst data
Altman Z
1.9
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NINOF buys
0
MRK buys
0
No recent congressional trades found for NINOF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNINOFMRK
Forward yield1.97%2.76%
Annual dividend / share$0.27$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-17.6%32.7%
Portfolio after 10y$20.9K$56.8K
Annual income after 10y$30.23$9,798.13
Total dividends collected$814.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NINOF vs MRK ($10,000, DRIP)

YearNINOF PortfolioNINOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,863$162.63$11,206$366.19$343.00MRK
2$11,759$136.05$12,650$502.35$891.00MRK
3$12,696$113.41$14,407$694.19$1.7KMRK
4$13,679$94.30$16,585$967.82$2.9KMRK
5$14,714$78.24$19,342$1,363.89$4.6KMRK
6$15,809$64.81$22,913$1,947.19$7.1KMRK
7$16,969$53.63$27,662$2,823.89$10.7KMRK
8$18,202$44.33$34,159$4,173.35$16.0KMRK
9$19,512$36.62$43,337$6,308.80$23.8KMRK
10$20,908$30.23$56,776$9,798.13$35.9KMRK

NINOF vs MRK: Complete Analysis 2026

NINOFStock

Nikon Corporation manufactures and sells optical instruments in Japan, North America, Europe, China, Thailand, and internationally. It operates through Imaging Products Business, Precision Equipment Business, Healthcare Business, Components Business, and Industrial Metrology and Others segments. The Imaging Products Business segment provides digital SLR cameras, compact digital cameras, and interchangeable camera lenses. The Precision Equipment Business segment offers FPD lithography systems and semiconductor lithography systems. The Healthcare Business segment provides biological microscopes, cell culture observation systems, and ultra-wide field retinal imaging devices, as well as products and services related to the contract cell development and manufacturing field. The Components Business segment offers optical components, optical parts, encoders, and material processing products and services; EUV-related components and space-related solutions; and photomask substrates for FPDs. The Industrial Metrology and Others segment provides industrial microscopes, non-contact 3D metrology systems, measuring instruments, X-ray/CT inspection systems, and surveying instruments. The company also offers optical lenses, sport optics products, optical glasses, molded optical glasses, camera components, and ophthalmic lenses. In addition, it sells used equipment; provides maintenance services for FPD/semiconductor lithography systems; sells and services cameras, microscopes, measuring instruments, and X-ray inspection equipment; and develops and supports computer software. Further, the company is involved in the procurement, logistics, and employee welfare activities; development, manufacturing, and testing services for cell-based therapeutics; and assembly of camera units. Nikon Corporation was incorporated in 1917 and is headquartered in Tokyo, Japan.

Full NINOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NINOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NINOF vs SCHDNINOF vs JEPININOF vs ONINOF vs KONINOF vs MAINNINOF vs JNJNINOF vs ABBVNINOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.